In very preterm infants, exposure to hyperoxia has been associated with worse neurological outcome. In the immature rodent brain, white matter damage (WMD) and perturbed myelination can be caused by hyperoxia via oxidative stress, inflammation, and apoptotic cell death. Decreased proliferation and delayed maturation of oligodendroglial precursor cells (OPC) have been found to contribute to WMD. The antibiotic minocycline exerts pleiotropic neuroprotective effects in various models of hypoxia/ischemia or inflammatory neurodegenerative diseases and is therefore a promising candidate for protection against hyperoxia-mediated brain injury.
